These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7529258)

  • 1. Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.
    Zapf J; Hauri C; Futo E; Hussain M; Rutishauser J; Maack CA; Froesch ER
    J Clin Invest; 1995 Jan; 95(1):179-86. PubMed ID: 7529258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.
    Zapf J; Hauri C; Waldvogel M; Froesch ER
    J Clin Invest; 1986 Jun; 77(6):1768-75. PubMed ID: 3711334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
    Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
    Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human insulin-like growth factor-I in diabetic rats.
    Higaki K; Matsumoto Y; Fujimoto R; Kurosaki Y; Kimura T
    Drug Metab Dispos; 1997 Nov; 25(11):1324-7. PubMed ID: 9351911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and fetal hypophysectomy on porcine preadipocytes: insulin-like growth factor-I (IGF-I) response, receptor binding and IGF binding proteins secretion.
    Chen NX; Hausman GJ; Wright JT
    Growth Dev Aging; 1995; 59(4):193-206. PubMed ID: 8770611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3).
    Sommer A; Spratt SK; Tatsuno GP; Tressel T; Lee R; Maack CA
    Growth Regul; 1993 Mar; 3(1):46-9. PubMed ID: 7683528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I.
    Böni-Schnetzler M; Gosteli-Peter MA; Moritz W; Froesch ER; Zapf J
    Biochem Biophys Res Commun; 1996 Aug; 225(1):296-301. PubMed ID: 8769133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds.
    Hamon GA; Hunt TK; Spencer EM
    Growth Regul; 1993 Mar; 3(1):53-6. PubMed ID: 7683531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.
    Zapf J; Hauri C; Waldvogel M; Futo E; Häsler H; Binz K; Guler HP; Schmid C; Froesch ER
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3813-7. PubMed ID: 2471192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin-like growth factor binding protein complexes on human fibroblast growth.
    Tesch GH; Cornell HJ; Herington AC; Oakes S
    Growth Regul; 1993 Jun; 3(2):151-9. PubMed ID: 7687915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage.
    Morales TI
    Arch Biochem Biophys; 1997 Jul; 343(2):164-72. PubMed ID: 9224726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of recombinant barramundi and human insulin-like growth factor (IGF)-I in juvenile barramundi (Lates calcarifer): in vivo metabolic effects, association with circulating IGF-binding proteins, and tissue localisation.
    Degger B; Upton Z; Soole K; Collet C; Richardson N
    Gen Comp Endocrinol; 2000 Mar; 117(3):395-403. PubMed ID: 10764550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
    Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced modulation of insulin like-growth factor-I action on glucose level in control and fasted rats.
    Mnich Z; Pałka J
    Med Sci Monit; 2001; 7(1):42-8. PubMed ID: 11208491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
    Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
    J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth.
    Schmid C; Schläpfer I; Keller A; Waldvogel M; Froesch ER; Zapf J
    Biochem Biophys Res Commun; 1995 Jul; 212(1):242-8. PubMed ID: 7541985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I.
    Scheiwiller E; Guler HP; Merryweather J; Scandella C; Maerki W; Zapf J; Froesch ER
    Nature; 1986 Sep 11-17; 323(6084):169-71. PubMed ID: 3528867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins.
    Cascieri MA; Saperstein R; Hayes NS; Green BG; Chicchi GG; Applebaum J; Bayne ML
    Endocrinology; 1988 Jul; 123(1):373-81. PubMed ID: 2454805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.